FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912993657> ?p ?o ?g. }

• W2912993657 endingPage "288" @default.
• W2912993657 startingPage "288" @default.
• W2912993657 abstract "Breast cancer will be diagnosed in 12% of women in the United States over the course of their lifetimes and more than 250 000 new cases of breast cancer were diagnosed in the United States in 2017. This review focuses on current approaches and evolving strategies for local and systemic therapy of breast cancer.Breast cancer is categorized into 3 major subtypes based on the presence or absence of molecular markers for estrogen or progesterone receptors and human epidermal growth factor 2 (ERBB2; formerly HER2): hormone receptor positive/ERBB2 negative (70% of patients), ERBB2 positive (15%-20%), and triple-negative (tumors lacking all 3 standard molecular markers; 15%). More than 90% of breast cancers are not metastatic at the time of diagnosis. For people presenting without metastatic disease, therapeutic goals are tumor eradication and preventing recurrence. Triple-negative breast cancer is more likely to recur than the other 2 subtypes, with 85% 5-year breast cancer-specific survival for stage I triple-negative tumors vs 94% to 99% for hormone receptor positive and ERBB2 positive. Systemic therapy for nonmetastatic breast cancer is determined by subtype: patients with hormone receptor-positive tumors receive endocrine therapy, and a minority receive chemotherapy as well; patients with ERBB2-positive tumors receive ERBB2-targeted antibody or small-molecule inhibitor therapy combined with chemotherapy; and patients with triple-negative tumors receive chemotherapy alone. Local therapy for all patients with nonmetastatic breast cancer consists of surgical resection, with consideration of postoperative radiation if lumpectomy is performed. Increasingly, some systemic therapy is delivered before surgery. Tailoring postoperative treatment based on preoperative treatment response is under investigation. Metastatic breast cancer is treated according to subtype, with goals of prolonging life and palliating symptoms. Median overall survival for metastatic triple-negative breast cancer is approximately 1 year vs approximately 5 years for the other 2 subtypes.Breast cancer consists of 3 major tumor subtypes categorized according to estrogen or progesterone receptor expression and ERBB2 gene amplification. The 3 subtypes have distinct risk profiles and treatment strategies. Optimal therapy for each patient depends on tumor subtype, anatomic cancer stage, and patient preferences." @default.
• W2912993657 created "2019-02-21" @default.
• W2912993657 creator A5070245248 @default.
• W2912993657 creator A5089866079 @default.
• W2912993657 date "2019-01-22" @default.
• W2912993657 modified "2023-10-14" @default.
• W2912993657 title "Breast Cancer Treatment" @default.
• W2912993657 cites W1464936406 @default.
• W2912993657 cites W1701849548 @default.
• W2912993657 cites W1770259999 @default.
• W2912993657 cites W1864994387 @default.
• W2912993657 cites W1982866065 @default.
• W2912993657 cites W2067420088 @default.
• W2912993657 cites W2075894019 @default.
• W2912993657 cites W2084370697 @default.
• W2912993657 cites W2087179076 @default.
• W2912993657 cites W2095659509 @default.
• W2912993657 cites W2096027508 @default.
• W2912993657 cites W2096499183 @default.
• W2912993657 cites W2096785769 @default.
• W2912993657 cites W2098775844 @default.
• W2912993657 cites W2099067294 @default.
• W2912993657 cites W2100025800 @default.
• W2912993657 cites W2101760255 @default.
• W2912993657 cites W2101979288 @default.
• W2912993657 cites W2103320273 @default.
• W2912993657 cites W2103608035 @default.
• W2912993657 cites W2113344831 @default.
• W2912993657 cites W2114292229 @default.
• W2912993657 cites W2115432999 @default.
• W2912993657 cites W2118696602 @default.
• W2912993657 cites W2118728607 @default.
• W2912993657 cites W2122428334 @default.
• W2912993657 cites W2123528875 @default.
• W2912993657 cites W2128585633 @default.
• W2912993657 cites W2129825983 @default.
• W2912993657 cites W2131719808 @default.
• W2912993657 cites W2133865595 @default.
• W2912993657 cites W2137086207 @default.
• W2912993657 cites W2137228442 @default.
• W2912993657 cites W2137853125 @default.
• W2912993657 cites W2142875113 @default.
• W2912993657 cites W2144124503 @default.
• W2912993657 cites W2146384083 @default.
• W2912993657 cites W2146478870 @default.
• W2912993657 cites W2149876820 @default.
• W2912993657 cites W2149908785 @default.
• W2912993657 cites W2159427817 @default.
• W2912993657 cites W2159967578 @default.
• W2912993657 cites W2161977537 @default.
• W2912993657 cites W2162960834 @default.
• W2912993657 cites W2163017141 @default.
• W2912993657 cites W2166199281 @default.
• W2912993657 cites W2169031890 @default.
• W2912993657 cites W2190954851 @default.
• W2912993657 cites W2214029008 @default.
• W2912993657 cites W2214665719 @default.
• W2912993657 cites W2267844613 @default.
• W2912993657 cites W2289933199 @default.
• W2912993657 cites W2335332412 @default.
• W2912993657 cites W2409054761 @default.
• W2912993657 cites W2415372857 @default.
• W2912993657 cites W2517421365 @default.
• W2912993657 cites W2519353639 @default.
• W2912993657 cites W2528767298 @default.
• W2912993657 cites W2552099557 @default.
• W2912993657 cites W2557607078 @default.
• W2912993657 cites W2560836545 @default.
• W2912993657 cites W2588881638 @default.
• W2912993657 cites W2593104572 @default.
• W2912993657 cites W2595349270 @default.
• W2912993657 cites W2606920283 @default.
• W2912993657 cites W2609520523 @default.
• W2912993657 cites W2616354594 @default.
• W2912993657 cites W2617437931 @default.
• W2912993657 cites W2618058692 @default.
• W2912993657 cites W2620993107 @default.
• W2912993657 cites W2621271973 @default.
• W2912993657 cites W2622135610 @default.
• W2912993657 cites W2622482306 @default.
• W2912993657 cites W2624590002 @default.
• W2912993657 cites W2740659413 @default.
• W2912993657 cites W2763875663 @default.
• W2912993657 cites W2765912935 @default.
• W2912993657 cites W2765942869 @default.
• W2912993657 cites W2767600184 @default.
• W2912993657 cites W2768980003 @default.
• W2912993657 cites W2774580734 @default.
• W2912993657 cites W2793265277 @default.
• W2912993657 cites W2794185840 @default.
• W2912993657 cites W2805213545 @default.
• W2912993657 cites W2805575723 @default.
• W2912993657 cites W2805734855 @default.
• W2912993657 cites W2806866264 @default.
• W2912993657 cites W2886477543 @default.
• W2912993657 cites W2897422388 @default.
• W2912993657 cites W2953390364 @default.
• W2912993657 cites W4243550142 @default.

• next